Senior CRA - 100% home based in the UK Edinburgh, Scotland
Job description
Our Clinical Operations department in the UK is looking for 4 Senior CRAs to work mainly on complex Oncology trials. You can be based anywhere in the UK but we do need previous UK monitoring experience.
The role in summary:
- National monitoring across the UK
- Studies will be 90% Oncology, so complex protocols
- ONC trials will include various solid tumor studies, Prostate, NSCLC, Leukemia, Breast, Glioblastoma and studies in Hematological malignancies.
- Other TAs include Respiratory, Cardiovascular, Infectious disease, Nephrology, Endocrinology, & Gastroenterology.
- On average each CRA will work across 5-6 Protocols (3-4 OCN plus “something else”)
- Risk based monitoring model
- Min of 8 days on site per month
USPs:
- Development! 3 years at Labcorp equates to 5 at a Pharma company
- Potential to become a CTL in 3 years.
- Routes into CTL, QA & Line Management roles
- Movement into FSP (client dedicated roles) and Clinical Pharmacology (1st in man trials)
- Our Line Managers are warm and open individuals who have a flexible and supportive approach.
- It’s not an official program but we do buddy Sen CRAs up with new hires or juniors. We also use the SCRA to develop our IHCRAs that are training to be travelling CRAs. The SCRAs take the juniors on site visits and they can be involved in the formal classroom training too.
As a leading global contract research organization (CRO) with a passion for scientific rigor and decades of clinical development experience, Fortrea provides pharmaceutical, biotechnology, and medical device customers a wide range of clinical development, patient access and technology solutions across more than 20 therapeutic areas. With over 19,000 staff conducting operations in more than 90 countries, Fortrea is transforming drug and device development for partners and patients across the globe.
Did you know?
Labcorp's Clinical Development and Commercialization Services business is now Fortrea in connection with its planned spin-off from Labcorp, which is expected in mid-2023. Fortrea’s spin-off from Labcorp is subject to satisfaction of certain customary conditions. This spin-off will position both organizations for accelerated growth and allow each to focus resources on distinct strategic priorities, customer and employee needs and value creation opportunities. As a provider of phase I-IV clinical trial management, regulatory guidance, patient access solutions and market access consulting, Fortrea will partner with both emerging and large pharmaceutical, biotechnology, device and diagnostic companies to drive healthcare innovation and improve the lives of patients worldwide.
Fortrea is looking for problem-solvers and creative thinkers who are passionate about breaking down barriers faced by sponsors of clinical trials, and who are committed to helping transform the development process to get promising life-changing ideas and therapies to patients faster. Join us as we cultivate a workspace where all employees have the opportunity to grow and make impacts on a global scale. For more information and questions related to Fortrea, please visit www.fortrea.com.
Labcorp is proud to be an Equal Opportunity Employer:
As an EOE/AA employer, Labcorp strives for diversity and inclusion in the workforce and does not tolerate harassment or discrimination of any kind. We make employment decisions based on the needs of our business and the qualifications of the individual and do not discriminate based upon race, religion, color, national origin, gender (including pregnancy or other medical conditions/needs), family or parental status, marital, civil union or domestic partnership status, sexual orientation, gender identity, gender expression, personal appearance, age, veteran status, disability, genetic information, or any other legally protected characteristic. We encourage all to apply.
For more information about how we collect and store your personal data, please see our Privacy Statement.
